Epigenomics (journal)
![]() | |
Discipline | Epigenomics |
---|---|
Language | English |
Edited by | James G. Herman, Jörg Tost |
Publication details | |
History | 2009–present |
Publisher | Future Medicine Ltd |
Frequency | Monthly |
4.778 (2020) | |
Standard abbreviations | |
ISO 4 | Epigenomics |
Indexing | |
CODEN | EPIGC7 |
ISSN | 1750-1911 (print) 1750-192X (web) |
OCLC no. | 746948365 |
Links | |
Epigenomics is a peer-reviewed medical journal established in 2009 and published by Future Medicine. The editors-in-chief are James G. Herman (University of Pittsburgh Cancer Institute) and Jörg Tost ( ). The journal covers all aspects of research on epigenomics and epigenetics and their implications for diagnosis, prognosis and therapeutics.
Abstracting and indexing[]
The journal is abstracted and indexed in EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Chemical Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2017 impact factor of 4.979, ranking it 31st out of 166 journals in the category "Genetics & Heredity".[1]
References[]
- ^ "Journals Ranked by Impact: Genetics & Heredity". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
External links[]
Categories:
- Publications established in 2009
- Medical genetics journals
- English-language journals
- Epigenetics
- Future Science Group academic journals